Steven R. Hagen

Steven R. Hagen appears in our data through filings on Albany Molecular Research Inc shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 31 January 2016 to 4 February 2016.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 8 February 2016, the filings show a share grant in Albany Molecular Research Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.